Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FSPG PET/CT in Intracranial Cancers
NCT02370563Phase 1Terminated
- Sponsor
- Life Molecular Imaging
- Start
- Nov 2014
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Life Molecular Imaging. Primary endpoint: Location and number of lesions and their location as detected by 18F-FSPG uptake above background in the brain. Started Nov 2014; status: terminated.
Beyond the preview
Go deeper on NCT02370563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370563.